We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£129.99
About as cheap as it gets — within 5% of the all-time low it hit 3 months ago.
£130 today · all-time low £124 (Jul 2026) · usually £129
Elsevier Academic Press Tumor Immunology and Immunotherapy Vol 636
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 71 days · 71 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 71 days • 4 price levels
Price Analysis
Most common price: £133 (39 days, 54.9%)
Price range: £124 - £133
Price levels: 4 different prices over 71 days
Description
Key Features
This Academic Press publication is part of the Methods in Enzymology series, Volume 636.
Includes specialized chapters on quantification methods for Transforming Growth Factor beta (TGF-beta) activity in cancer immunotherapy.
Provides in vivo methods for decoding cancer cell death-driven immune cell recruitment during site-of-vaccination analyses.
Covers technical approaches for tracking and interrogating both tissue-resident and recruited microglia in brain tumors.
Features research focused on the metabolomics and lipidomics of the tumor microenvironment.
Product Specifications
- Brand
- Elsevier
- Format
- hardcover
- ASIN
- 0128206675
- Domain
- Amazon UK
- Release Date
- 26 March 2020
- Listed Since
- 11 September 2019
Barcode
No barcode data available
Similar Products You Might Like
Tumor Immunology and Immunotherapy - Integrated Methods Part A: Volume 635 (Methods in Enzymology, Volume 635)
Elsevier
Tumor Immunology and Immunotherapy – Cellular Methods Part A (Volume 631) (Methods in Enzymology, Volume 631)
Elsevier
Biology of T Cells - Part A (Volume 341) (International Review of Cell and Molecular Biology, Volume 341)
Elsevier
Biology of T Cells - Part B: Volume 342 (International Review of Cell and Molecular Biology, Volume 342)
Elsevier
Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)
CRC Press
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
Humana
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
Springer
Immunotherapy of Cancer: Innovative Treatment Comes of Age
Springer
T Lymphocytes Subpopulations in Immunotoxicology
Wiley
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)
Springer
Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
Springer
Immunotherapy in Translational Cancer Research (Translational Oncology)
Wiley
Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance
Elsevier
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
Humana
Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)
Springer
Immunodiagnosis and Immunotherapy of Malignant Tumors: Relevance to Surgery
Springer
Developments in T Cell Based Cancer Immunotherapies (Cancer Drug Discovery and Development)
Humana
Novel Immunotherapeutic Approaches to Cancer Treatment - Springer
Springer
Clinical Immuno-Oncology
Elsevier
Novel Immunotherapeutic Approaches to Cancer Treatment - Springer
Springer
Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
Elsevier
Cancer Vaccines as Immunotherapy of Cancer
Elsevier
Cancer Immunology: A Translational Medicine Context
Springer